Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.9%

1 terminated out of 52 trials

Success Rate

96.4%

+9.9% vs benchmark

Late-Stage Pipeline

10%

5 trials in Phase 3/4

Results Transparency

4%

1 of 27 completed with results

Key Signals

1 with results96% success

Data Visualizations

Phase Distribution

43Total
Not Applicable (36)
P 2 (2)
P 3 (1)
P 4 (4)

Trial Status

Completed27
Unknown19
Recruiting3
Not Yet Recruiting2
Terminated1

Trial Success Rate

96.4%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (52)

Showing 20 of 20 trials
NCT06151431Not ApplicableCompletedPrimary

Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension in Preeclamptic Patients

NCT07556731Phase 3Not Yet Recruiting

Comparison of Ferrous Salt vs. Liposomal Iron in Adult Women With Iron-Deficiency Anemia

NCT07366853Not ApplicableNot Yet RecruitingPrimary

Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach

NCT06158022Not ApplicableCompletedPrimary

ED90 of Norepinephrine and Phenylephrine Infusions in Preeclamptic Patients

NCT03706755Phase 4Completed

Comparison of Two Doses of Norepinephrine in Preventing Hypotension After Spinal Anesthesia

NCT06158048Not ApplicableCompletedPrimary

ED90 of Norepinephrine and Phenylephrine Infusions Under Intensive Treatment

NCT06570616Not ApplicableRecruiting

Addressing Unintentional Leakage When Using Nasal CPAP - Study A

NCT06570629Not ApplicableRecruiting

Addressing Unintentional Leakage When Using Nasal CPAP - Study B

NCT06871449CompletedPrimary

Investigation Of The Effects Of Unilateral And Bilateral Spinal Anesthesia On Cerebral Blood Flow

NCT05743985Not ApplicableCompleted

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

NCT06467045Recruiting

Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging

NCT05475886Not ApplicableUnknownPrimary

6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension

NCT05712018Not ApplicableCompletedPrimary

Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine

NCT06158035Not ApplicableUnknownPrimary

ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment in Preeclamptic Patients

NCT06158009Not ApplicableUnknownPrimary

ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment

NCT06151522Not ApplicableUnknownPrimary

90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment

NCT06151444Not ApplicableUnknownPrimary

Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients

NCT06151470Not ApplicableUnknownPrimary

90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients

NCT06151457Not ApplicableUnknownPrimary

90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients

NCT06151509Not ApplicableUnknownPrimary

90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment

Scroll to load more

Research Network

Activity Timeline